Markets had expected the central bank to keep its benchmark interest rate steady while setting up a cut at the July meeting.The Fedread more
The stream is slated to start at 2:30 pm ETThe Fedread more
This is a comparison of Wednesday's FOMC statement with the one issued on May 1 after the Fed's previous policy-making meeting.The Fedread more
Powell said policymakers are concerned about some of the recent economic developments and see a growing case for easier policy.The Fedread more
The Fed chief said that despite reports that Trump was looking to demote or fire him, he doesn't plan on leaving anytime soon.The Fedread more
If you're concerned about what Wednesday's Fed decision means for your bank account, mortgage loan or credit card — as well as student debt, home equity loan and car payment —...Personal Financeread more
The Federal Open Market Committee's quarterly economic forecast includes the so-called dot plot of where members see interest rates heading.The Fedread more
Employees spoke out on issues like forced arbitration, workplace equity and Project Dragonfly at Alphabet's annual shareholder meeting.Technologyread more
The Federal Reserve lowered its inflation forecast for 2019 while keeping the growth expectations unchanged.The Fedread more
With bold and targeted steps, economists say, government can increase opportunity and incomes for many more people in ways that strengthen, not weaken, American capitalism.Politicsread more
G is for Google—and glucose monitoring, as it turns out.
Google's life sciences team announced a partnership with glucose monitoring company Dexcom Tuesday to develop smaller, cheaper cloud-connected glucose sensors that hope to make finger sticks a thing of the past.
"We're committed to developing new technologies that will help move health care from reactive to proactive,"Andrew Conrad, head of the life sciences team at Google said in a statement. "This collaboration is another step towards expanding monitoring options and making it easier for people with diabetes to proactively manage their health."
Under the agreement, the initial products mainly utilize DexCom's experience with sensor technology. However, Google will add value by way of its knowledge in miniaturized electronics and real-time data, with the objective of creating a device no larger than a bandage.
The companies did not disclose when the product might be available, but did reveal DexCom would retain all sales and distribution rights for the monitor, along with other payment and royalty arrangements.
The tech giant already has a toehold in the health sciences sector.
Earlier this week, in addressing why Google was restructuring into Alphabet, CEO Larry Page highlighted many of the products and initiatives in the health space. Those include a patented glucose-sensing smart contact lens it's developing in partnership with Swiss drugmaker Novartis.
Success for the companies could shake up a blood-sugar tracking market that is expected to be worth more than $12 billion by 2017, according to GlobalData research cited by Reuters.